Regal Assets Analytics

Bill Langbein

SanaCurrents closing out Adverum Biotechnologies (ADVM)

By |2020-11-21T11:33:39-05:00November 17th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Adverum Biotechnologies (NASDAQ:ADVM) on Saturday reported positive results from its [...]

SanaCurrents Pivotal Sentiment on Protagonist (PTGX) polycythemia vera phase II trial

By |2020-11-17T10:15:51-05:00November 14th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Probability Sentiment [...]

Adverum catalyst set for Saturday, November 14

By |2020-11-17T10:16:00-05:00November 11th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Adverum Biotechnologies (NASDAQ:ADVM) said it will present additional clinical data [...]

Calliditas’ Shares Soar About 35% After Hitting Catalyst

By |2020-11-09T12:00:46-05:00November 9th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Sweden-based Calliditas Therapeutics’ (NASDAQ:CALT) delivered on its phase III trial [...]

SanaCurrents Advantageous Sentiment on Alimera Sciences, Inc. (ALIM) Revenue Growth

By |2020-11-09T09:33:07-05:00November 7th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Alimera Sciences, Inc. (NASDAQ:ALIM) Probability Sentiment [...]

FDA Places Partial Clinical Hold on Molecular Templates Trial; SanaCurrents Suspending Coverage

By |2020-11-06T10:39:56-05:00November 6th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: |

In an earnings release after the market closed on November [...]

Annexon, Inc. (ANNX) Probability Sentiment

By |2020-10-31T17:19:12-04:00October 31st, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

$ANNX Probability Sentiment FEATURED CATALYST [...]